AMIH Majority Owned Subsidiary, EPIQ Scripts, Obtains Controlled Substance Registration from the U.S. Department of Justice & Drug Enforcement Administration (DEA)
December 01, 2022 10:30 ET
|
American International Holdings Corp.
EPIQ Scripts has also submitted applications for various nationally recognized accreditation agencies and associations Dallas, Texas, Dec. 01, 2022 (GLOBE NEWSWIRE) -- American International...
AMIH Subsidiary EPIQ Scripts Receives Pharmacy License with Texas State Board of Pharmacy
June 16, 2022 09:00 ET
|
American International Holdings Corp.
Dallas, Texas, June 16, 2022 (GLOBE NEWSWIRE) -- American International Holdings Corp. (OTCQB: AMIH)(“AMIH” or the “Company”), a diversified holding company that develops, acquires and operates...
American International Holdings Corp. Launches EPIQ Scripts Online Mail-Order Pharmacy
February 15, 2022 09:00 ET
|
American International Holdings Corp.
Adds to AMIH’s Portfolio of Complementary Technology Driven, Consumer Focused Healthcare Companies Plano, Texas, Feb. 15, 2022 (GLOBE NEWSWIRE) -- American International Holdings Corp. (OTCQB:...